fundamental analysis of aurobindo pharma stock

22
Fundamental Analysis Aurobindo Pharma By: Ashish Sharma I am ONN [email protected]

Upload: ashish-sharma

Post on 15-Apr-2017

318 views

Category:

Economy & Finance


2 download

TRANSCRIPT

Page 1: Fundamental Analysis of Aurobindo Pharma Stock

Fundamental Analysis

Aurobindo Pharma 

By: Ashish Sharma I am ONN [email protected]

Page 2: Fundamental Analysis of Aurobindo Pharma Stock

Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals

Among the largest ' Vertically Integrated ' pharmaceutical companies in India

Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995.

Introduction

Page 3: Fundamental Analysis of Aurobindo Pharma Stock

Sun Pharmaceuticals was established by Mr. Dilip Shanghvi in 1983 in Vapi with five products to treat psychiatry ailments.

Sun Pharma was listed on the stock exchange in 1994 in an issue oversubscribed 55 times.

Sun Pharma is the second largest and the most profitable pharmaceutical company in India, as well as the largest pharmaceutical company by market capitalisation on the Indian exchanges.[

Introduction

Page 4: Fundamental Analysis of Aurobindo Pharma Stock

The company was founded by Anji Reddy in 1984

Dr. Reddy's Laboratories, is a multinational pharmaceutical company based in Hyderabad Telangana India.

Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care and biotechnology products.

Introduction

Page 5: Fundamental Analysis of Aurobindo Pharma Stock

In 1935, Dr. K. A. Hamied set up Cipla to make India self-reliant in healthcare.

Today, Cipla is one of the world’s largest generic pharmaceutical companies with a strong presence in over 170 countries

We have over 2000 products in 65 therapeutic categories; with over 40 dosage forms, covering a wide spectrum of diseases ranging from communicable, non-communicable, common and emerging diseases to even rare diseases.

Introduction

Page 6: Fundamental Analysis of Aurobindo Pharma Stock

Current Ratio

2010 2011 2012 2013 20140

0.5

1

1.5

2

2.5

3

3.5

4

AurobindoIndustry Average

Page 7: Fundamental Analysis of Aurobindo Pharma Stock

Quick Ratio

2010 2011 2012 2013 20140

0.5

1

1.5

2

2.5

AurobindoIndustry Average

Page 8: Fundamental Analysis of Aurobindo Pharma Stock

Debt Equity Ratio

2010 2011 2012 2013 20140

0.2

0.4

0.6

0.8

1

1.2

AurobindoIndustry Average

Page 9: Fundamental Analysis of Aurobindo Pharma Stock

Interest Coverage Ratio

2010 2011 2012 2013 2014

-50

0

50

100

150

200

250

300 Chart Title

AurobindoIndustry Average

Page 10: Fundamental Analysis of Aurobindo Pharma Stock

Debtors Turnover Ratio

2010 2011 2012 2013 20140

10

20

30

40

50

60

70

80

90

100

AurobindoIndustry Average

Page 11: Fundamental Analysis of Aurobindo Pharma Stock

Creditors Turnover Ratio

2010 2011 2012 2013 20140

20

40

60

80

100

120

140

160

180

200

AurobindoIndustry Average

Page 12: Fundamental Analysis of Aurobindo Pharma Stock

Stock Turnover Ratio

2010 2011 2012 2013 20140

50

100

150

200

250

300

350

400

AurobindoIndustry Average

Page 13: Fundamental Analysis of Aurobindo Pharma Stock

Gross Profit Ratio

2010 2011 2012 2013 20140

10

20

30

40

50

60

70

80

AurobindoIndustry Average

Page 14: Fundamental Analysis of Aurobindo Pharma Stock

Net Profit Ratio

2010 2011 2012 2013 2014

-5

0

5

10

15

20

25

AurobindoIndustry Average

Page 15: Fundamental Analysis of Aurobindo Pharma Stock

Return on Asset

2010 2011 2012 2013 2014-2

0

2

4

6

8

10

12

14

16

AurobindoIndustry Average

Page 16: Fundamental Analysis of Aurobindo Pharma Stock

Return On Capital Employed

2010 2011 2012 2013 2014-2

0

2

4

6

8

10

12

14

AurobindoIndustry Average

Page 17: Fundamental Analysis of Aurobindo Pharma Stock

Price Earning Ratio

2010 2011 2012 2013 2014

-30

-20

-10

0

10

20

30

AurobindoIndustry Average

Page 18: Fundamental Analysis of Aurobindo Pharma Stock

Earning Per Share

2010 2011 2012 2013 2014

-20

0

20

40

60

80

100

120

AurobindoIndustry Average

Page 19: Fundamental Analysis of Aurobindo Pharma Stock

Book Value Per Share

2010 2011 2012 2013 20140

50

100

150

200

250

300

350

AurobindoIndustry Average

Page 20: Fundamental Analysis of Aurobindo Pharma Stock

Dividend Per Share

2010 2011 2012 2013 20140

1

2

3

4

5

6

7

8

9

10

AurobindoIndustry Average

Page 21: Fundamental Analysis of Aurobindo Pharma Stock

Dividend Yield Ratio

2010 2011 2012 2013 20140

5

10

15

20

25

30

AurobindoIndustry Average

Page 22: Fundamental Analysis of Aurobindo Pharma Stock

Cash FlowYear CFO PAT

2009-10 4287.4 5634.0

2010-11 3433.7 5634.5

2011-12 3262.1 -1235

2012-13 2748.7 2938.6

2013-14 6462.8 11728.5